LOGSX — Live Oak Health Sciences Fund
Data updated: 2026-06-29
LOGSX — Live Oak Health Sciences Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $49.52M AUM · 1.04% expense ratio · 14.1% 1-yr return. From SEC regulatory filings.
LOGSX Fund Overview
LOGSX — Live Oak Health Sciences Fund is a US mutual fund managed by Oak Associates Funds, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Oak Associates Funds
- Category: United States Health Care Equity
- Assets under management: $49.52M
- 1-year return: 14.1%
- Ticker: LOGSX
- SEC CIK: 0001050918
- SEC series ID: S000006542
- Share class ID: C000017877
LOGSX Holdings
Top 10 holdings of Live Oak Health Sciences Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| United Therapeutics Corp. | 6.40% |
| Cardinal Health, Inc. | 5.57% |
| Jazz Pharmaceuticals PLC | 5.25% |
| Novartis AG | 5.01% |
| Cencora, Inc. | 5.00% |
| Amgen, Inc. | 4.95% |
| Mount Vernon Liquid Assets Portfolio, LLC | 4.90% |
| Mckesson Corp. | 4.89% |
| Exelixis, Inc. | 4.71% |
| Regeneron Pharmaceuticals, Inc. | 4.66% |
LOGSX Portfolio Allocation
Asset-class allocation of Live Oak Health Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 96.8% |
| Cash & Equivalents | 8.1% |
LOGSX Performance
Total returns for LOGSX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.3% |
| 1 year | 14.1% |
| 3 years (annualised) | 7.3% |
| 5 years (annualised) | 5.8% |
LOGSX Risk Information
Risk metrics for LOGSX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.0%
LOGSX Costs and Fees
LOGSX costs about $104 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.04%
- Gross expense ratio: 1.04%
- Portfolio turnover: 24%
- Brokerage commissions: 1.25 bps of average net assets (SEC N-CEN)
LOGSX Cashflows
Over the 12 months to 2026-04, Live Oak Health Sciences Fund had net outflows of $5.67M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $13.98K |
| 2026-03 | $331.72K |
| 2026-02 | −$1.92M |
| 2026-01 | −$867.16K |
| 2025-12 | $1.03M |
| 2025-11 | −$2.66M |
LOGSX Debt Constituents
No individual debt constituents are reported in Live Oak Health Sciences Fund's latest SEC N-PORT filing.
LOGSX Prospectus and SEC Filings
Official Live Oak Health Sciences Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.